In light of recent reports that World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus is backtracking on his support for a waiver on COVID-19 vaccine patents to be expanded to diagnostics …
African Insight Informs AHF’s Pandemic Governance and Funding Recommendations
In a collaborative effort to reshape global health policy discourse, the AHF Global Public Health Institute, in partnership with the University of Miami Public Health Policy Lab and AHF Africa …
AHF Honors the Memory of Chinese Activist-Clinician Dr. Gao
AIDS Healthcare Foundation (AHF) today commemorated the life and work of Chinese HIV/AIDS clinician and advocate Dr. Gao Yaojie, who brought to light the HIV epidemic in rural China caused by tainted …
AHF Calls for China’s Full Transparency on Spike in Respiratory Illnesses
Following the Associated Press reporting that the World Health Organization requested that China provide more data on a ”potentially worrying spike in respiratory illnesses and clusters of pneumonia in children” publicly, AIDS …
AHF Demands WHO ‘Make it Right’ for Sex Abuse Survivors
Following a damning Associated Press article reporting that the World Health Organization paid over 100 Congolese survivors of sexual abuse at the hands of its staffers a mere $250 each, AIDS Healthcare Foundation (AHF) …
AHF Echoes WTO’s Call for Patent Flexibilities
AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling on developing countries to put in place legal mechanisms to suspend …
AHF Applauds Novel Gonorrhea Treatment
AIDS Healthcare Foundation (AHF) applauds promising clinical trial results for a new drug zoliflodacin, which was co-developed by Swiss nonprofit Global Antibiotic Research & Development Partnership and U.S.-based company Innoviva Specialty …
AHF Urges Affordable Access to New Dengue Drug
The AIDS Healthcare Foundation (AHF) commends Johnson & Johnson (J&J) for developing a pill that has shown promising results in a small trial for protecting against dengue fever and urges …
Patients Suffer as Pfizer Pockets Profits
The AIDS Healthcare Foundation (AHF) rebuked pharmaceutical giant Pfizer today for announcing that it plans to charge $1,400 for a five-day course of the COVID-19 antiviral drug Paxlovid. During the pandemic, the U.S. government …
Africa Needs Vaccines to Fight Mpox, Wealthy Countries Must Act
With a deadly endemic mpox (formerly monkeypox) strain ravaging parts of Africa, particularly the Democratic Republic of the Congo, due to little-to-no vaccine access on the continent, AIDS Healthcare Foundation (AHF) urges the Global North to …
